VITI PHARMACEUTICALS, LLC

VITI PHARMACEUTICALS, LLC specializes in the manufacturing of sterile and oral pharmaceutical preparations for federal healthcare systems, with deep expertise in producing generic active pharmaceutical ingredients and finished dosage forms under cGMP standards. The company delivers mission-critical medications—including antihyperlipidemics like fenofibrate, antidiabetics such as metformin, and specialized formulations like bariatric multivitamins—to meet the precise therapeutic needs of veteran populations. Their technical capabilities encompass formulation development, batch processing, quality control testing, and supply chain compliance aligned with FDA and VA pharmacopeial requirements, ensuring consistent product integrity across high-volume production cycles. The contractor maintains a sustained and trusted relationship with the Department of Veterans Affairs, consistently supplying pharmaceuticals to its network of Community-Based Outpatient Clinics and Centralized Manufacturing Operations. Their work supports VA’s national formulary initiatives by providing reliable, cost-effective generic medications that ensure continuity of care for enrolled veterans, particularly in chronic disease management and post-surgical recovery protocols. VITI PHARMACEUTICALS operates primarily within NAICS 325412, focusing on the end-to-end manufacturing of prescription pharmaceuticals, with specialization in oral solid dosage forms and targeted therapeutic categories such as metabolic, cardiovascular, and nutritional support products. Their market positioning is defined by agility in fulfilling urgent, high-volume VA supply demands while maintaining strict adherence to pharmaceutical quality systems and regulatory documentation standards. As a Women-Owned Small Business and Woman-Owned Business certified entity headquartered in Miami, Florida, VITI PHARMACEUTICALS leverages its small business status to enhance accessibility and responsiveness within federal procurement channels. The company’s operational footprint is centered on compliant, scalable manufacturing infrastructure designed to meet the stringent demands of government pharmaceutical procurement.